These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 92563)

  • 21. Relationship between phosphatidylserine and cromolyn in histamine release.
    Read GW; Knoohuizen M; Goth A
    Eur J Pharmacol; 1977 Mar; 42(2):171-7. PubMed ID: 66150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of histamine and serotonin release from rat mast cells induced by thymic peptides.
    Erjavec F; Ferjan I
    Agents Actions; 1991 May; 33(1-2):30-2. PubMed ID: 1716834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histamine-releasing effect of a corticotrophin derivative. II. Mechanism of action of histamine release by C 44 680-Ba, compared with that of Cpd. 48/80, dextran and triton.
    Rüegg M
    Agents Actions; 1979 Jun; 9(2):148-54. PubMed ID: 89804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histamine-releasing effect of a corticotrophin derivative. I. Histamine-releasing effect of a nonadecapeptide in comparison with that of other histamine liberators.
    Rüegg M; Jaques R
    Pharmacology; 1977; 15(2):134-42. PubMed ID: 66701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism of action of fire ant (Solenopsis) venoms. I. Lytic release of histamine from mast cells.
    Lind NK
    Toxicon; 1982; 20(5):831-40. PubMed ID: 6184853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of characteristics of current-type and conventional-type cationic bactericides.
    Ohta S; Misawa Y; Miyamoto H; Makino M; Nagai K; Shiraishi T; Nakagawa Y; Yamato S; Tachikawa E; Zenda H
    Biol Pharm Bull; 2001 Sep; 24(9):1093-6. PubMed ID: 11558578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protamine-like property of compounds 48/80 and stilbamidine and their action on mast cells.
    MOTA I; BERALDO WT; JUNQUEIRA CU
    Proc Soc Exp Biol Med; 1953 Jul; 83(3):455-7. PubMed ID: 13088875
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuraminidase- and benzalkonium chloride-dependent inhibition of basic peptide-induced rat mast cell secretion.
    Coleman JW
    Immunol Lett; 1982 Oct; 5(4):197-201. PubMed ID: 7173980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzalkonium Chloride Disinfectants Induce Apoptosis, Inhibit Proliferation, and Activate the Integrated Stress Response in a 3-D
    Herron JM; Tomita H; White CC; Kavanagh TJ; Xu L
    Chem Res Toxicol; 2021 May; 34(5):1265-1274. PubMed ID: 33472002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological and functional changes after benzalkonium chloride treatment of the small intestinal Thiry-Vella loop in rats.
    Móricz K; Gyetvai B; Bárdos G
    Brain Res Bull; 1998 Aug; 46(6):519-28. PubMed ID: 9744289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quaternary ammonium compounds in hypersensitivity reactions.
    Peyneau M; de Chaisemartin L; Gigant N; Chollet-Martin S; Kerdine-Römer S
    Front Toxicol; 2022; 4():973680. PubMed ID: 36211198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC.
    George M; Joshi SV; Concepcion E; Lee H
    Respir Med Case Rep; 2017; 21():39-41. PubMed ID: 28377880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel designed polyoxyethylene nonionic surfactant with improved safety and efficiency for anticancer drug delivery.
    Li C; Sun C; Li S; Han P; Sun H; Ouahab A; Shen Y; Xu Y; Xiong Y; Tu J
    Int J Nanomedicine; 2014; 9():2089-100. PubMed ID: 24812509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzalkonium chloride induced bronchoconstriction in patients with stable bronchial asthma.
    Lee BH; Kim SH
    Korean J Intern Med; 2007 Dec; 22(4):244-8. PubMed ID: 18309682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaphylaxis caused by benzalkonium in a nebulizer solution.
    Kim SH; Ahn Y
    J Korean Med Sci; 2004 Apr; 19(2):289-90. PubMed ID: 15082905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug events related to dosage forms and delivery systems.
    Uchegbu IF; Florence AT
    Drug Saf; 1996 Jan; 14(1):39-67. PubMed ID: 8713487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-protein ligands inhibit in vitro reactions of vacuole inheritance.
    Haas A; Conradt B; Wickner W
    J Cell Biol; 1994 Jul; 126(1):87-97. PubMed ID: 8027189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives.
    Purcell WM; Atterwill CK
    Neurochem Res; 1995 May; 20(5):521-32. PubMed ID: 7643958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin E decapeptide-induced 5-hydroxytryptamine release from rat peritoneal mast cells. Comparison with corticotropin-(1-24)-peptide, polyarginine, polylysine and antigen.
    Coleman JW; Holgate ST; Church MK; Godfrey RC
    Biochem J; 1981 Sep; 198(3):615-9. PubMed ID: 7326027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On disturbance of homeostasis in organ-cultured tissue.
    Norrby K; Bergström S; Druvefors P
    In Vitro; 1984 Aug; 20(8):607-14. PubMed ID: 6209203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.